Sutro Biopharma (STRO) Short-term Investments (2018 - 2025)

Sutro Biopharma (STRO) has 8 years of Short-term Investments data on file, last reported at $83.3 million in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments fell 34.2% year-over-year to $83.3 million; the trailing twelve-month figure through Dec 2025 stood at $83.3 million (down 34.2% YoY), and the FY2025 full-year result was $83.3 million, down 34.2% from the prior year.
• Short-term Investments slipped to $83.3 million in Q4 2025, from $101.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $284.8 million in Q2 2024 to a low of $33.3 million in Q2 2023.
• A 5-year average of $134.0 million and a median of $135.7 million in 2021 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments plunged 83.56% in 2023 and surged 753.94% in 2024, its largest moves.
• Tracing STRO's Short-term Investments over 5 years: stood at $130.3 million in 2021, then soared by 95.71% to $255.1 million in 2022, then sank by 83.56% to $41.9 million in 2023, then soared by 201.86% to $126.6 million in 2024, then tumbled by 34.2% to $83.3 million in 2025.
• Business Quant data shows STRO's Short-term Investments at $83.3 million in Q4 2025, $101.7 million in Q3 2025, and $141.1 million in Q2 2025.